783 related articles for article (PubMed ID: 28566290)
1. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
2. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
3. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
4. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
6. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
[TBL] [Abstract][Full Text] [Related]
7. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
8. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
[TBL] [Abstract][Full Text] [Related]
9. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
10. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
[TBL] [Abstract][Full Text] [Related]
11. Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement.
Berntorp K; Koul S; Nozohoor S; Harnek J; Bjursten H; Götberg M
BMC Cardiovasc Disord; 2019 Feb; 19(1):44. PubMed ID: 30808296
[TBL] [Abstract][Full Text] [Related]
12. Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.
Pilgrim T; Stortecky S; Nietlispach F; Heg D; Tueller D; Toggweiler S; Ferrari E; Noble S; Maisano F; Jeger R; Roffi M; Grünenfelder J; Huber C; Wenaweser P; Windecker S
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27856487
[TBL] [Abstract][Full Text] [Related]
13. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation.
Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
[TBL] [Abstract][Full Text] [Related]
15. Balloon-expandable transaortic transcatheter aortic valve implantation with or without predilation.
Bonaros N; Kofler M; Frank D; Cocchieri R; Jagielak D; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Bapat V; Rein KA; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Romano M
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):915-923. PubMed ID: 29221741
[TBL] [Abstract][Full Text] [Related]
16. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
Ferrera C; Nombela-Franco L; Garcia E; Jimenez-Quevedo P; Biagioni C; Gonzalo N; Nuñez-Gil I; Viana-Tejedor A; Salinas P; Alberto de Agustin J; Almeria C; Islas F; Perez de Isla L; Fernandez-Perez C; Escaned J; Fernández-Ortiz A; Macaya C
Catheter Cardiovasc Interv; 2017 Nov; 90(5):809-816. PubMed ID: 27515377
[TBL] [Abstract][Full Text] [Related]
17. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
[TBL] [Abstract][Full Text] [Related]
18. Pre-Existing Right Bundle Branch Block Increases Risk for Death After Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.
Watanabe Y; Kozuma K; Hioki H; Kawashima H; Nara Y; Kataoka A; Nagura F; Nakashima M; Shirai S; Tada N; Araki M; Takagi K; Yamanaka F; Yamamoto M; Hayashida K
JACC Cardiovasc Interv; 2016 Nov; 9(21):2210-2216. PubMed ID: 27832846
[TBL] [Abstract][Full Text] [Related]
19. Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves.
Husser O; Kim WK; Pellegrini C; Holzamer A; Walther T; Mayr PN; Joner M; Kasel AM; Trenkwalder T; Michel J; Rheude T; Kastrati A; Schunkert H; Burgdorf C; Hilker M; Möllmann H; Hengstenberg C
JACC Cardiovasc Interv; 2017 Oct; 10(20):2078-2087. PubMed ID: 29050625
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry.
Hahn RT; Pibarot P; Leipsic J; Blanke P; Douglas PS; Weissman NJ; Kapadia S; Thourani VH; Herrmann HC; Nazif T; McAndrew T; Webb JG; Leon MB; Kodali S
JACC Cardiovasc Interv; 2018 Sep; 11(17):1710-1718. PubMed ID: 30121276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
